Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists.

de Sousa-Pereira P, Abrantes J, Bauernfried S, Pierini V, Esteves PJ, Keppler OT, Pizzato M, Hornung V, Fackler OT, Baldauf HM.

J Gen Virol. 2018 Dec 19. doi: 10.1099/jgv.0.001201. [Epub ahead of print]

PMID:
30566072
2.

SERINC5 as a New Restriction Factor for Human Immunodeficiency Virus and Murine Leukemia Virus.

Firrito C, Bertelli C, Vanzo T, Chande A, Pizzato M.

Annu Rev Virol. 2018 Sep 29;5(1):323-340. doi: 10.1146/annurev-virology-092917-043308.

PMID:
30265629
3.

S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.

Chande A, Cuccurullo EC, Rosa A, Ziglio S, Carpenter S, Pizzato M.

Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13197-13202. Epub 2016 Nov 1.

4.

MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.

Pizzato M.

Proc Natl Acad Sci U S A. 2010 May 18;107(20):9364-9. doi: 10.1073/pnas.1001554107. Epub 2010 May 3.

Supplemental Content

Loading ...
Support Center